NEURALIS s.a.
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Single and Multiple Intravenous Administrations of Estetrol (E4) in Healthy Adult Volunteers (NCT05460065) | NEURALIS s.a. | 2022-04-19 |
| Estetrol (E4) for the Treatment of Patients With Confirmed SARS-COV-2 Infection (NCT04801836) | NEURALIS s.a. | 2020-11-19 |
Track NEURALIS s.a. automatically
Every clearance here is in the API, with alerts when new ones post.